Sm. Thompson et al., MECHANISMS UNDERLYING THE NEUROPATHOLOGICAL CONSEQUENCES OF EPILEPTICACTIVITY IN THE RAT HIPPOCAMPUS IN-VITRO, Journal of comparative neurology, 372(4), 1996, pp. 515-528
Blockade of gamma-aminobutyric acid (GABA)ergic synaptic transmission
in mature hippocampal slice cultures for a period of 3 days with convu
lsants was shown previously to induce chronic epileptiform activity an
d to mimic many of the degenerative changes observed in the hippocampi
of epileptic humans. The cellular mechanisms underlying the induction
of this degeneration were examined in the present study by comparing
the effects of GABA blockers with the effects produced by the K+ chann
el blocker tetraethylammonium (2 mM). Both types of convulsant caused
a comparable decrease in the number of Nissl-stained pyramidal cells i
n areas CA1 and CA3. No significant cell loss was induced by tetraethy
lammonium when epileptiform discharge was reduced by simultaneous expo
sure of cultures to tetrodotoxin (0.5 mu M) or to the anticonvulsants
pentobarbital (50 mu M) or tiagabine (50 mu M). We conclude that this
degeneration was mediated by convulsant-induced epileptiform discharge
itself. The hypothesis that N-methyl-D-aspartate (NMDA) receptor-medi
ated excitotoxicity underlies cell death in this model was tested by a
pplying convulsants together with specific antagonists of glutamate re
ceptors. Whereas coapplication of antagonists of both non-NMDA and NMD
A receptors strongly reduced the degeneration induced by the convulsan
ts, application of either class of antagonist alone did not. Applicati
on of exogenous NMDA produced potent cell death, and this degeneration
was blocked by the NMDA receptor antagonist yl-10,11-dihydro-5-H-dibe
nzocyclohepten-5,10-imine (MK-801). Convulsants also induced a loss of
dendritic spines that could be partially prevented by NMDA or non-NMD
A receptor antagonists. We conclude that NMDA receptor activation is n
ot solely responsible for the neuronal pathology resulting as a conseq
uence of epileptiform discharge. (C) 1996 Wiley-Liss, Inc.